Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.

Lacout, Alexis; Lounnas, Valere; Perronne, Christian

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.

Lacout, Alexis; Lounnas, Valere; Perronne, Christian.

Lacout A; Centre de diagnostic, ELSAN, Centre médico-chirurgical, Aurillac France. Electronic address: lacout.alexis@wanadoo.fr.
Lounnas V; EMBL Heidelberg Alumni, Heidelberg, Germany.
Perronne C; Infectious Diseases Unit, University Hospital Raymond Poincaré, APHP, Versailles Saint Quentin University, Garches, France.

Int J Antimicrob Agents ; 57(4): 106314, 2021 04.

Article in English | MEDLINE | ID: covidwho-1272464

Subject(s)

COVID-19 Drug Treatment; Hydroxychloroquine; Aged; Azithromycin; Drug Therapy, Combination; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Limits: Aged / Humans Language: English Journal: Int J Antimicrob Agents Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google